tiprankstipranks
Diaceutics (DE:7DC)
FRANKFURT:7DC
Germany Market
7DC
Diaceutics
RESEARCH TOOLSreports

Diaceutics (7DC) Income Statement

0 Followers

Diaceutics Income Statement

Last quarter (Q4 2025), Diaceutics's total revenue was £23.87M, an increase of 73.31% from the same quarter last year. In Q4, Diaceutics's net income was £2.50M. See Diaceutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
£ 38.44M£ 32.16M£ 23.70M£ 19.50M£ 13.94M
Gross Profit
£ 26.12M£ 28.27M£ 19.71M£ 14.04M£ 10.57M
Operating Expenses
£ 25.88M£ 30.73M£ 22.72M£ 13.71M£ 10.25M
Depreciation and Amortization
£ 5.81M£ 4.63M£ 4.77M£ 3.01M£ 1.80M
EBITDA
£ 6.08M£ 2.77M£ 2.36M£ 3.61M£ 2.35M
Operating Income
£ 266.00K£ -2.46M£ -3.02M£ 575.00K£ 550.00K
Other Income/Expenses
£ -26.00K£ 547.00K£ 580.00K£ -11.00K£ -88.00K
Pretax Income
£ 240.00K£ -1.91M£ -2.44M£ 564.00K£ 462.00K
Net Income
£ 97.00K£ -1.70M£ -1.75M£ 724.00K£ 561.00K
Per Share Metrics
Basic EPS
£ <0.01£ -0.02£ -0.02£ <0.01£ 0.01
Diluted EPS
£ <0.01£ -0.02£ -0.02£ <0.01£ 0.01
Weighted Average Shares Outstanding
 84.58M 84.45M 84.23M 84.15M 83.94M
Weighted Average Shares Outstanding (Diluted)
 85.13M 84.45M 84.23M 86.09M 84.94M
Currency in GBP

Diaceutics Earnings and Revenue History